Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kastelein

Showing results (41-50 of 184) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|February 24, 2001
Review of first 5 years of screening for familial hypercholesterolaemia in the NetherlandsM A Umans-Eckenhausen, J C Defesche, E J Sijbrands, et al.
The Journal of Clinical Investigation|January 1, 1997
Tetrahydrobiopterin restores endothelial function in hypercholesterolemiaE Stroes, J Kastelein, F Cosentino, et al.
Human Molecular Genetics|April 1, 1993
The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoformsY Y van der Hoek, M E Wittekoek, U Beisiegel, et al.
The American Journal of Cardiology|February 15, 1995
Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizabilityS J Bredie, T W de Bruin, P N Demacker, et al.
Clinical Drug Investigation|August 13, 2016
Efficacy of Concentrated n-3 Fatty Acids in Hypertriglyceridaemia : A Comparison with GemfibrozilM van Dam, A F Stalenhoef, J Wittekoek, et al.
The American Journal of Medicine|November 10, 2015
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?Sripal Bangalore, Rana Fayyad, John J Kastelein, et al.
Atherosclerosis|September 16, 1999
Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C]L Yu, E Heere-Ress, B Boucher, et al.
The Journal of Clinical Investigation|July 15, 1996
An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease)J A Kuivenhoven, H Weibusch, P H Pritchard, et al.
Clinical Drug Investigation|January 15, 2013
Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) StudyT J Smilde, M D Trip, H Wollersheim, et al.
Archives of Internal Medicine|October 25, 1993
Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemiaJ C Defesche, K L Pricker, M R Hayden, et al.
Pageof 19

Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|February 24, 2001
Review of first 5 years of screening for familial hypercholesterolaemia in the NetherlandsM A Umans-Eckenhausen, J C Defesche, E J Sijbrands, et al.
The Journal of Clinical Investigation|January 1, 1997
Tetrahydrobiopterin restores endothelial function in hypercholesterolemiaE Stroes, J Kastelein, F Cosentino, et al.
Human Molecular Genetics|April 1, 1993
The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoformsY Y van der Hoek, M E Wittekoek, U Beisiegel, et al.
The American Journal of Cardiology|February 15, 1995
Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizabilityS J Bredie, T W de Bruin, P N Demacker, et al.
Clinical Drug Investigation|August 13, 2016
Efficacy of Concentrated n-3 Fatty Acids in Hypertriglyceridaemia : A Comparison with GemfibrozilM van Dam, A F Stalenhoef, J Wittekoek, et al.
The American Journal of Medicine|November 10, 2015
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?Sripal Bangalore, Rana Fayyad, John J Kastelein, et al.
Atherosclerosis|September 16, 1999
Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C]L Yu, E Heere-Ress, B Boucher, et al.
The Journal of Clinical Investigation|July 15, 1996
An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease)J A Kuivenhoven, H Weibusch, P H Pritchard, et al.
Clinical Drug Investigation|January 15, 2013
Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) StudyT J Smilde, M D Trip, H Wollersheim, et al.
Archives of Internal Medicine|October 25, 1993
Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemiaJ C Defesche, K L Pricker, M R Hayden, et al.
Pageof 19